Fingerprint
Dive into the research topics of 'Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: Primary analysis of fixed-dosing, long-term outcome of weight-based dosing'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically